Company

CHARM Therapeutics

Research Services London, City of, United Kingdom 58 employees

Employees: 58
Contacts: 2
Emails: 2

www.charmtx.com LinkedIn Crunchbase

CHARM Therapeutics Overview

Headquarters: London, City of, United Kingdom
Website: www.charmtx.com
Industry: Research Services
Employees: 58
Founded: 2021
Funding: 20.0M
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients.

About CHARM Therapeutics

CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients.

CHARM Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

CHARM Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Adrian Woolfson	Founder of Genyro. Board Director	San Francisco Bay Area, United States	Email
Peter Canning	Principal Scientist, Protein Sciences	Royston, England, United Kingdom	Email
Sebastien Degorce	VP, Medicinal Chemistry		View